Does plasminogen activator inhibitor-1 drive lymphangiogenesis?
Bruyère
Françoise
F
Laboratory of Tumor and Development Biology, Groupe Interdisciplinaire de Génoprotéomique Appliqué-Cancer, University of Liège, Liège, Belgium.
Melen-Lamalle
Laurence
L
Blacher
Silvia
S
Detry
Benoît
B
Masset
Anne
A
Lecomte
Julie
J
Lambert
Vincent
V
Maillard
Catherine
C
Høyer-Hansen
Gunilla
G
Lund
Leif R
LR
Foidart
Jean-Michel
JM
Noël
Agnès
A
D000818:Animals; D000952:Antigens, Polyomavirus Transforming / Q000378:metabolism; D045744:Cell Line, Tumor; D005260:Female; D006579:Heterozygote; D006801:Humans; D007249:Inflammation; D008202:Lymphangioma / Q000378:metabolism; D008297:Male; D008324:Mammary Tumor Virus, Mouse / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D009362:Neoplasm Metastasis; D017395:Plasminogen Activator Inhibitor 1 / Q000502:physiology*
D000952:Antigens, Polyomavirus Transforming; D017395:Plasminogen Activator Inhibitor 1